MergerMay 8, 2026, 04:23 PM
ASPAC III Acquisition Corp. Enters $217.86M Merger Agreement with Bioserica
AI Summary
ASPAC III Acquisition Corp. has entered into a definitive merger agreement with Bioserica International Limited, valuing Bioserica at $217.86 million. This follows the termination of a previous agreement with HD Group. The company faces significant challenges, including substantial shareholder redemptions of 5,717,419 Class A shares for $59.5 million, leaving only $2.9 million in the trust account. Management has also raised substantial doubt about the company's ability to continue as a going concern if a business combination is not completed by November 12, 2026.
Key Highlights
- Entered merger agreement with Bioserica International Limited for $217.86 million.
- Consideration for Bioserica includes 20,000,000 PubCo Class B shares and 1,786,000 PubCo Class A shares.
- Shareholders redeemed 5,717,419 Class A ordinary shares for $59,502,058 at the 2025 EGM.
- Approximately $2.9 million remained in the Trust Account after redemptions.
- Combination Period extended to November 12, 2026, following shareholder approval.
- Reported a net loss of $(113,988) for Q1 2026, compared to net income of $413,202 in Q1 2025.
- Cash decreased to $670,328 as of March 31, 2026, from $871,350 at December 31, 2025.
- Management identified substantial doubt about the company's ability to continue as a going concern.